Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
30.2M
-
Shares change
-
+639K
-
Total reported value, excl. options
-
$368M
-
Value change
-
+$3.28M
-
Put/Call ratio
-
0.68
-
Number of buys
-
78
-
Number of sells
-
-72
-
Price
-
$12.18
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q4 2021
208 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.2M shares
of 54.8M outstanding shares and own 55.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.2M shares), VANGUARD GROUP INC (3.03M shares), FARALLON CAPITAL MANAGEMENT LLC (2M shares), DISCIPLINED GROWTH INVESTORS INC /MN (1.66M shares), STATE STREET CORP (1.5M shares), Chescapmanager LLC (1.3M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (925K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (883K shares), GEODE CAPITAL MANAGEMENT, LLC (841K shares), and C WorldWide Group Holding A/S (583K shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.